CD44 and pancreatic neoplasm: Pancreatic CSCs have been identified both in patient tumors by their expression of the cell surface markers ESA (epithelial surface antigen; CD326), CD44 and CD24 [6] and in murine pancreatic tumors with a slightly different panel of markers (CD44+, CD133+, Sca1+) [7].